IRCT20200127046282N13
Recruiting
Phase 1
Study of safety and effectiveness of mesenchymal stem cells condition medium in the treatment of hair loss (phases I and II )
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Hair loss.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 45
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who do not want to take minoxidil.
- •Patients who are allergic to minoxidil.
Exclusion Criteria
- •The patient has used an effective drug in hair loss during the last 6 months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Comparison of the efficacy of mesenchymal stem cells condition medium injection and ow level laser in the treatment of alopeciaIRCT20200127046282N27Shahid Beheshti University of Medical Sciences30
Completed
Not Applicable
Effects of mesenchymal stem cells therapy in peritoneal dialysis patientsChronic kidney disease.Chronic kidney disease, stage 5IRCT2015052415841N2Vice chancellor for research, Tehran University of Medical Sciences10
Completed
Phase 1
Mesenchymal Stromal Cells to Treat Steroid-refractory Graft Versus Host Disease after Bone Marrow TransplantatioGraft Versus Host DiseaseInflammatory and Immune System - Other inflammatory or immune system disordersBlood - Haematological diseasesACTRN12610000068066R.P.Herrmann20
Not yet recruiting
Not Applicable
Safety and Efficacy of MCA-derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients: The Nereid Study*BPARrejection transplanted kidney10038430NL-OMON53310eids Universitair Medisch Centrum16
Completed
Not Applicable
To investigate the efficacy of mesenchymal stem cell conditioned media (MSCs-CM) on ameliorate maturation and developmental potential of immature human oocytes after artificial activation in the infertile female.IRCT2017101736840N1Vice Chancellor for Research, Kerman University of Medical Sciences100